Upregulating human cathelicidin antimicrobial peptide LL-37 expression may prevent severe COVID-19 inflammatory responses and reduce microthrombosis
KM Aloul, JE Nielsen, EB Defensor, JS Lin… - Frontiers in …, 2022 - frontiersin.org
COVID-19 is characterized by hyperactivation by inflammatory cytokines and recruitment of
macrophages, neutrophils, and other immune cells, all hallmarks of a strong inflammatory …
macrophages, neutrophils, and other immune cells, all hallmarks of a strong inflammatory …
Role of LL-37 in thrombotic complications in patients with COVID-19
Z Duan, J Zhang, X Chen, M Liu, H Zhao, L Jin… - Cellular and Molecular …, 2022 - Springer
Blood clot formation induced by dysfunctional coagulation is a frequent complication of
coronavirus disease 2019 (COVID-19) and a high-risk factor for severe illness and death …
coronavirus disease 2019 (COVID-19) and a high-risk factor for severe illness and death …
The ratio of serum LL-37 levels to blood leucocyte count correlates with COVID-19 severity
M Keutmann, G Hermes, D Meinberger, A Roth… - Scientific Reports, 2022 - nature.com
Beneficial effects of vitamin D on COVID-19 progression have been discussed in several
studies. Vitamin D stimulates the expression of the antimicrobial peptide LL-37, and …
studies. Vitamin D stimulates the expression of the antimicrobial peptide LL-37, and …
LL-37 fights SARS-CoV-2: the vitamin D-inducible peptide LL-37 inhibits binding of SARS-CoV-2 spike protein to its cellular receptor angiotensin converting enzyme 2 …
A Roth, S Lütke, D Meinberger, G Hermes, G Sengle… - BioRxiv, 2020 - biorxiv.org
Objective Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the pathogen
accountable for the coronavirus disease 2019 (COVID-19) pandemic. Viral entry via binding …
accountable for the coronavirus disease 2019 (COVID-19) pandemic. Viral entry via binding …
Human cathelicidin inhibits SARS-CoV-2 infection: killing two birds with one stone
C Wang, S Wang, D Li, P Chen, S Han… - ACS infectious …, 2021 - ACS Publications
SARS-CoV-2 infection begins with the association of its spike 1 (S1) protein with host
angiotensin-converting enzyme-2 (ACE2). Targeting the interaction between S1 and ACE2 …
angiotensin-converting enzyme-2 (ACE2). Targeting the interaction between S1 and ACE2 …
[HTML][HTML] Cathelicidin LL-37 bloodstream surveillance is down regulated during septic shock
DF Barbeiro, HV Barbeiro, FG Zampieri… - Microbes and …, 2013 - Elsevier
Host defense peptides are ancient weapons of the innate immunity. The human cathelicidin
LL-37 protects the epithelial barrier against infection and is constitutively secreted in the …
LL-37 protects the epithelial barrier against infection and is constitutively secreted in the …
Interleukin-37 is down-regulated in serum of patients with severe coronavirus disease 2019 (COVID-19)
AA Ahmed, AH Ad'hiah - Cytokine, 2021 - Elsevier
Pro-inflammatory and anti-inflammatory cytokines are indicated to play a prominent role in
mediating the immunopathogenesis of coronavirus disease 19 (COVID-19). Interleukin (IL …
mediating the immunopathogenesis of coronavirus disease 19 (COVID-19). Interleukin (IL …
Novel insights into the role of anti-inflammatory IL-38 in immunity against infection
X Gao, G Wu, MSM Tsang, D Huang… - Cellular & Molecular …, 2022 - nature.com
Since the identification and cloning of interleukin (IL)-38 in 2001, a plethora of studies have
focused on its essential roles as a novel IL-1 family cytokine in both innate and acquired …
focused on its essential roles as a novel IL-1 family cytokine in both innate and acquired …
LL-37 directs macrophage differentiation toward macrophages with a proinflammatory signature
AM van der Does, H Beekhuizen… - The journal of …, 2010 - journals.aai.org
The human cathelicidin LL-37 has broad-spectrum antimicrobial activity. It also participates
at the interface of innate and adaptive immunity by chemoattracting immune effector cells …
at the interface of innate and adaptive immunity by chemoattracting immune effector cells …
Preliminary evaluation of the safety and efficacy of oral human antimicrobial peptide LL-37 in the treatment of patients of COVID-19, a small-scale, single-arm …
H Zhang, Y Zhao, X Jiang, Y Zhao, L Yang, L Chen… - MedRxiv, 2020 - medrxiv.org
Abstract Background& Aims The Coronavirus Disease 2019 (COVID-19) has become a
global epidemic and has caused a lasting and huge loss of life security, economic …
global epidemic and has caused a lasting and huge loss of life security, economic …
相关搜索
- ll 37 covid 19
- sars cov human cathelicidin
- ll 37 macrophage differentiation
- ll 37 thrombotic complications
- thrombotic complications covid 19
- serum of patients covid 19
- ll 37 proinflammatory signature
- human platelets antimicrobial activity
- preliminary evaluation covid 19
- safety and efficacy covid 19
- coronavirus disease covid 19
- interleukin 37 covid 19
- treatment of patients covid 19